Walter Narajowski is listed as a director on 10 SEC Form D filings by 1 issuer between Nov 2023 and Aug 2026: Nuclein, LLC (Austin, TX — biotechnology — 2023–2026; $19.1M reported sold to 49 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Alan Blake (10 shared filings), Richard Crockett (10 shared filings), Sanjay Chandra (10 shared filings), William Cunningham (10 shared filings), H. David Shockley (9 shared filings) and 4 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Walter. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 10 public filings for Walter Narajowski and found 4 differences: Form D filed 18 days after the first sale; 5 offerings changed their target amount between filings; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.